|
|
|||||||||||||||||||||||
Go back to clinical information and images Diagnosis: Angiomyolipoma (monophasic or fat poor) Angiomyolipoma (AML) are tumours consisting of perivascular epithelioid cells (cells which are found surrounding blood vessels and which resemble epithelial cells). A tumour of this kind is known as a PEComa, from the initials of perivascular epithelioid cell. Older literature may classify them as hamartoma (benign tumours consisting of cells in their correct location but forming a disorganised mass) or choristoma (benign tumours consisting of normal cells in the wrong location). PEComas are themselves a kind of mesenchymal tumour. An AML is composed of varying proportions
of vessels, smooth muscle cells and fat cells. However, many pathologically
confirmed AMLs are not suspected on preoperative imaging due to an absence
of radiographically evident fat. The histological findings in these fat
poor AMLs can be typical or can be monophasic, with minimal or not evident
adipocytes. Clinical outcomes in patients with fat poor AMLs have AML composed predominantly (95% or more) of a single component (adipose tissue or smooth muscle) is called monophasic AML. If 95% or more of the tumor is smooth muscle it is called "fat poor angiomyolipoma" (Lane BR, et al. Clinical correlates of renal angiomyolipoma subtypes in 209 patients: classic, fat poor, tuberous sclerosis associated and epithelioid. J Urol. 2008;180:836-43. [PubMed link]). See the chapter Renal Neoplasms - Part 2 - of our tutorial (this chapter appears only in Spanish version). Go back to clinical information and images References
|
||||||||||||||||||||||||